Funding

SpectaCell

Belgium · Biotech

SpectaCell develops cell analysis instruments that combine chip-based imaging and data analysis for drug development and manufacturing.

Visit spectacell.comFunding history

Product

SpectaCell develops a platform for observing individual cells and their interactions over time. Its technology combines chip-based imaging with data analysis and is designed to work without fluorescent labels that could alter cell behaviour.

The Ghent company spun out of imec, VIB and Ghent University in 2026. It is developing a cartridge-based instrument for pharmaceutical and biotechnology teams, with intended uses from drug research and process development to manufacturing quality checks.

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed€6Mimec.xpand — LeadFlanders Future Tech Fund — ParticipantInnovationQuarter Capital — ParticipantQBIC — ParticipantVIB — Participant

Investors

imec.xpandLed SeedFlanders Future Tech FundJoined SeedInnovationQuarter CapitalJoined SeedQBICJoined SeedVIBJoined Seed

Coverage

Oct 9, 2026SpectaCell · Seed

Similar companies

BioGeometryBioGeometry develops generative AI models and experimental workflows for protein design, drug discovery and enzyme engineering.Undisclosed · Series A+
IntegriCultureIntegriCulture develops cell-culture systems and production technology for cellular foods, cosmetics and other biological materials.Undisclosed · Funding round
Atlas BioAtlas Bio develops AI models that simulate patient responses to help biopharma teams assess drug development decisions.$10M · Seed
Sourceseu-startups.com ↗